FDA Cites ZS Pharma Over Testing, Validation Problems

Drug Industry Daily
A A
The FDA cited ZS Pharma over testing and validation issues at its API manufacturing facility in Coppell, Texas.

To View This Article:

Login

Subscribe To Drug Industry Daily